Capecitabine Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 500 mg tablets 150 mg tablets
Reference Brands: Xeloda®(EU & US)
Category: Oncology Cancer Care
Capecitabine is available in Tablets and strengths such as 500 mg tablets 150 mg tablets. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Capecitabine is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Capecitabine can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Product Description: Capecitabine, marketed as Xeloda®, is an oral chemotherapy agent used in the treatment of breast cancer, colorectal cancer, and gastric cancer. As a prodrug of 5-fluorouracil (5-FU), Capecitabine is administered in 500 mg and 150 mg tablet strengths in both the US and EU markets. Its oral formulation makes it convenient for outpatient therapy and home administration. Manufactured under stringent GMP guidelines, Capecitabine is a crucial product for B2B oncology pharmaceutical companies targeting cancer care centers and oncology specialists. It presents significant opportunities for global distribution and licensing.
Frequently Asked Questions
Related Products
Atezolizumab
Strength:
1200 mg/20 mL
Form: Intravenous infusion
Reference Brands: Tecentriq® (EU & US)
View Details
Durvalumab
Strength:
120 mg/4 mL, 500 mg/10 mL
Form: Injection
Reference Brands: Imfinzi® (US & EU)
View Details
Sunitinib
Strength:
12.5 mg, 25 mg, 37.5 mg, 50 mg
Form: Tablet
Reference Brands: Sutent® (EU & US)
View DetailsQuick Response Guaranteed | Verified Suppliers
